BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6428801)

  • 1. Nondosage-dependent valproic acid-induced hyperammonemia and coma.
    Gaskins JD; Holt RJ; Postelnick M
    Clin Pharm; 1984; 3(3):313-6. PubMed ID: 6428801
    [No Abstract]   [Full Text] [Related]  

  • 2. Valproic acid-associated encephalopathy with coma.
    Settle EC
    Am J Psychiatry; 1995 Aug; 152(8):1236-7. PubMed ID: 7625483
    [No Abstract]   [Full Text] [Related]  

  • 3. Valproic acid-induced hyperammonaemic coma and unrecognised portosystemic shunt.
    Nzwalo H; Carrapatoso L; Ferreira F; Basilio C
    Epileptic Disord; 2013 Jun; 15(2):207-10. PubMed ID: 23774155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperammonemia and coma developed by a woman treated with valproic acid for affective disorder.
    Eze E; Workman M; Donley B
    Psychiatr Serv; 1998 Oct; 49(10):1358-9. PubMed ID: 9779913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.
    Mallet L; Babin S; Morais JA
    Ann Pharmacother; 2004 Oct; 38(10):1643-7. PubMed ID: 15316109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid and secondary hyperammonemia.
    Rawat S; Borkowski WJ; Swick HM
    Neurology; 1981 Sep; 31(9):1173-4. PubMed ID: 6791053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate-induced hyperammonemia.
    Batshaw ML; Brusilow SW
    Ann Neurol; 1982 Mar; 11(3):319-21. PubMed ID: 6807193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolic encephalopathy can be a potentially life-threatening complication from valproic acid].
    Meinardi MC; van den Berg GB; Groenhuijzen A; Driessen JT; Maas HA; Wolfhagen FH
    Ned Tijdschr Geneeskd; 2008 Feb; 152(5):278-82. PubMed ID: 18333544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hyperammonemic coma with chronic valproic acid therapy.
    Cuturic M; Abramson RK
    Ann Pharmacother; 2005 Dec; 39(12):2119-23. PubMed ID: 16288075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy.
    Barrueto F; Hack JB
    Acad Emerg Med; 2001 Oct; 8(10):999-1001. PubMed ID: 11581089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive side effects of valproic acid-induced hyperammonemia in children with epilepsy.
    Nicolai J; Aldenkamp AP; Huizenga JR; Teune LK; Brouwer OF
    J Clin Psychopharmacol; 2007 Apr; 27(2):221-4. PubMed ID: 17414255
    [No Abstract]   [Full Text] [Related]  

  • 12. Valproate-induced coma: case report and literature review.
    Duarte J; Macias S; Coria F; Fernandez E; Clavería LE
    Ann Pharmacother; 1993 May; 27(5):582-3. PubMed ID: 8347908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate-associated hyperammonemic encephalopathy.
    Wadzinski J; Franks R; Roane D; Bayard M
    J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Encephalopathy associated with hyperammonemia in an alcoholic patient treated with sodium valproate].
    Mattei A; Bernard G; Plauchu G; Paliard P
    Gastroenterol Clin Biol; 1993; 17(6-7):516-7. PubMed ID: 8243949
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hyperammonemia during sodium valproate therapy: clinically relevant or accidental finding?].
    Ettlin T; Scollo-Lavizzari G
    Schweiz Rundsch Med Prax; 1986 Jul; 75(29):881-5. PubMed ID: 3090672
    [No Abstract]   [Full Text] [Related]  

  • 16. Carbamyl phosphate synthetase-1 deficiency discovered after valproic acid-induced coma.
    Verbiest HB; Straver JS; Colombo JP; van der Vijver JC; van Woerkom TC
    Acta Neurol Scand; 1992 Sep; 86(3):275-9. PubMed ID: 1414247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperammonaemic encephalopathy due to valproic acid in the neonatal period].
    Jiménez-Parrilla F; Pérez-Sánchez A; Núñez-Solís JM; Madruga-Garrido M; Losada-Martínez A
    Rev Neurol; 2009 Jun 1-15; 48(11):613-4. PubMed ID: 19472163
    [No Abstract]   [Full Text] [Related]  

  • 18. Asymptomatic hyperammonemia in patients receiving valproic acid.
    Murphy JV; Marquardt K
    Arch Neurol; 1982 Sep; 39(9):591-2. PubMed ID: 6810855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperammonemic encephalopathy caused by sodium valproate].
    Kerleau JM; Bohu PA; Héron F; Manchon ND; Bourreille J
    Rev Med Interne; 1994 May; 15(5):363-4. PubMed ID: 8059166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.